AI Automated Translation.

Font Size

Share

Moderna supplies COVID-19 vaccine for high-risk infants and children in South Korea

Moderna supplies COVID-19 vaccine for high-risk infants and children in South Korea

Moderna Korea said Wednesday that it has completed the domestic supply of a total of 1,000 doses (one-time administration) of the infant and pediatric COVID-19 vaccine "Spikevax Prefilled Syringe (XFG variant response)" to support the prevention of COVID-19 in high-risk infants and children.

The supplied vaccines are scheduled to be administered through 59 designated medical institutions nationwide. Specific vaccination sites and related matters can be confirmed through the Disease Control and Prevention Agency's Vaccination Helper website and guidance from relevant agencies.

COVID-19 can progress to severe illness in infants and children as well. In particular, children with underlying conditions such as congenital heart disease, chronic lung disease, neurological and genetic disorders, or those in an immunocompromised state are known to have a high risk of hospitalization and severe disease.

Accordingly, the KDCA is implementing vaccinations for high-risk groups, including immunocompromised individuals aged 6 months and older, as part of the national preventive vaccination targets for the 2026-2027 season.

It was explained that this vaccine supply is the result of close cooperation over several months with government and related agencies, including the Disease Control and Prevention Agency, the Ministry of Food and Drug Safety, and the Korea Rare and Essential Medicines Center, to improve vaccination accessibility for high-risk infants and children.

Kim Sang-baek, president of Moderna Korea, said, "Regardless of the scale of vaccine supply, it is very important to provide vaccination opportunities to patients who need them," adding, "We will continue our efforts to enhance vaccine accessibility and contribute to improving public health in Korea."

"This article was translated using AI and may differ slightly from the original."